RxCelerate Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

RxCelerate General Information

Description

Operator of an outsourced drug discovery and development platform intended to specialize in non-clinical models of diseases. The company's platform offers bespoke efficacy models, including a study design that combines efficacy and toxicology end-points in a single study wrapper and specializes in bespoke experimental design with data-rich endpoints, enabling researchers to improve the productivity of drug discovery and development.

Contact Information

Website
www.rxcelerate.com
Formerly Known As
Tcp Biotech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Dorothy Hodgkin Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3FH
  • England, United Kingdom
+44 01223
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Other Pharmaceuticals and Biotechnology
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • The Dorothy Hodgkin Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3FH
  • England, United Kingdom
+44 01223

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RxCelerate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2015 Completed Generating Revenue
To view RxCelerate’s complete valuation and funding history, request access »

RxCelerate Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

RxCelerate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202219662-D0 Reagents for building to a binding site Active 23-Dec-2022
GB-2620811-A Reagents for binding to a binding site Active 23-Dec-2022
GB-2620811-B Reagents for binding to a binding site Active 23-Dec-2022 G16C20/50

RxCelerate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RxCelerate Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Total Medical Ventures Venture Capital Minority
To view RxCelerate’s complete investors history, request access »

RxCelerate Investments & Acquisitions (6)

RxCelerate’s most recent deal was a Merger/Acquisition with Methuselah Health. The deal was made on 22-Nov-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Methuselah Health 22-Nov-2022 Merger/Acquisition Biotechnology
Rivus Pharmaceuticals 19-Aug-2022 Early Stage VC Drug Discovery
Rivus Pharmaceuticals 20-Jul-2021 Early Stage VC Drug Discovery
Prosarix 05-Feb-2019 Merger/Acquisition Other Pharmaceuticals and Biotechnology
The Cambridge Partnership 08-May-2018 Merger/Acquisition Other Commercial Services
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

RxCelerate Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
RxBiologics Cambridge, United Kingdom 2017
Methuselah Health Cambridge, United Kingdom 2015
The Cambridge Partnership Cambridge, United Kingdom 2013
Prosarix Cambridge, United Kingdom 2006

RxCelerate FAQs

  • When was RxCelerate founded?

    RxCelerate was founded in 2012.

  • Where is RxCelerate headquartered?

    RxCelerate is headquartered in Cambridge, United Kingdom.

  • What is the size of RxCelerate?

    RxCelerate has 100 total employees.

  • What industry is RxCelerate in?

    RxCelerate’s primary industry is Drug Discovery.

  • Is RxCelerate a private or public company?

    RxCelerate is a Private company.

  • What is RxCelerate’s current revenue?

    The current revenue for RxCelerate is .

  • Who are RxCelerate’s investors?

    Total Medical Ventures has invested in RxCelerate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »